World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
119911
World Ranking
4245
National Ranking
19

Overview

Michael Gnant is affiliated with the Medical University of Vienna in Austria and has contributed extensively to research in oncology, particularly focusing on breast cancer. Their work spans multiple aspects of cancer biology, treatment, and clinical management, with a significant number of publications in esteemed journals.

Their main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with subfields concentrated in Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics, and Surgery. This multidisciplinary engagement reflects a comprehensive approach to cancer research and treatment development.

Key research topics addressed by Michael Gnant include:

  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Global Cancer Incidence and Screening
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer

Michael Gnant has coauthored numerous papers with other researchers, frequently collaborating with:

  • Christian F. Singer
  • Marija Balić
  • Florian Fitzal
  • Richard Greil
  • Dominik Hlauschek

Their publication record includes articles in prominent scientific journals. Frequent publication venues include:

  • Cancer Research
  • Journal of Clinical Oncology
  • The Breast
  • Annals of Oncology
  • Clinical Cancer Research

Recent papers authored or coauthored by Michael Gnant illustrate a focus on breast cancer therapies and clinical guidelines. Notable publications include:

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021, published in 2021 in Annals of Oncology
  • Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, published in 2023 in Annals of Oncology
  • Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer, published in 2022 in Annals of Oncology
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, published in 2021 in The Lancet Oncology
  • Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial, published in 2021 in Journal of Clinical Oncology

Best Publications

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    A.G. Olsson;J McMurray;G Thorgeirsson;C Spaulding

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

    R Turner;C Fox;Matthews;H McElroy

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

    UK Prospective Diabetes;RR Holman;SE Manley;R Turner

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • Prevention of neural tube defects: Results of the Medical Research Council vitamin study

    N Wald;J Sneddon;J Densem;C Frost

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

    José Baselga;Mario Campone;Martine Piccart;Howard A. Burris

  • Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

    J. F. Sneddon;J Densem;N Wald;C Frost

  • Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    A. S. Coates;E. P. Winer;A. Goldhirsch;R. D. Gelber

  • Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

    Michael Gnant;Brigitte Mlineritsch;Walter Schippinger;Gero Luschin-Ebengreuth

  • Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

    Raimund Jakesz;Walter Jonat;Michael Gnant;Martina Mittlboeck

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Mitch Dowsett;Jack Cuzick;Jim Ingle;Alan Coates

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

    J. Bergh;K. Pritchard;K. Albain;S. Anderson

  • A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky

  • Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

    Michael Gnant;Brigitte Mlineritsch;Herbert Stoeger;Gero Luschin-Ebengreuth

  • Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial

    Thomas M. Suter;Marion Procter;Dirk J. van Veldhuisen;Michael Muscholl

  • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

    Terje R Pedersen

Frequent Co-Authors

Raimund Jakesz
Raimund Jakesz Medical University of Vienna
Richard Greil
Richard Greil Paracelsus Medical University
Christian F. Singer
Christian F. Singer Medical University of Vienna
Christoph C. Zielinski
Christoph C. Zielinski Medical University of Vienna
Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Jonas Bergh
Jonas Bergh Karolinska Institute
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Martine Piccart
Martine Piccart Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees and career pathways can be a practical choice for those interested in medicine, especially with the flexibility of online study. There is a growing demand for roles in pharmacy, health informatics, medical billing, and nursing—all of which offer accredited online programs.

For students considering the pharmaceutical field, comparing online pharmacy school cost is key. Affordable options exist, but tuition rates and prerequisites vary widely. Similarly, health data specialists are in high demand, and earning a degree in health informatics can open doors to careers in hospital data management and healthcare analytics.

If you are interested in administrative roles, enrolling in online medical billing and coding courses can be a quick way to start working in healthcare. Those seeking advanced patient care roles should investigate the cheapest np programs online. These programs offer a pathway to a high-impact healthcare career while managing costs.

Best Scientists Citing Michael Gnant

Trending Scientists

Recently Published Articles